Stendra Avanafil Reduces Penile Fibrosis in American Men with Peyronie’s Disease: 5-Year Study
Reading Time: 3 minutes Introduction Peyronie's disease, a condition characterized by the development of fibrous scar tissue inside the penis, can lead to painful erections, curvature, and sexual dysfunction. This debilitating condition affects a significant number of American men, often leading to psychological distress and a reduced quality of life. Recent research has explored the potential of Stendra (avanafil), a phosphodiesterase type 5 (PDE5) inhibitor, in reducing the incidence of penile fibrosis associated with Peyronie's disease. This article presents a comprehensive analysis of a five-year follow-up study examining the efficacy of Stendra avanafil in American men with Peyronie's disease. Study Design and Methodology The...


